Note: Ingredients listed on restricted chemical lists
EC/CAS
872-50-4
Name of the chemical
N-Methyl-2-Pyrrolidone; 1-methyl-2-pyrrolidone (NMP)
Concentration
>=30-<50
EC/CAS
120068-37-3
Name of the chemical
Fipronil; 5-Amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile
Concentration
>=5-<10
General Information
Version
3.3
Revision date
2026-01-07
Product name
FRONTLINE TRI-ACT Spot-on, solution; FRONTLINE
Product Synonyms
Frontect® Spot-On Dog; Certishield®; Certishield® for Dogs; Frontect® Spot-On Dog; Certishield®; Certishield® for Dogs; Triact Frontect®, Frontline® TRI-ACT 0.5 mL - 6.0 mL with API: Fipronil and Permethrin
1.2.1 Relevant identified uses
Veterinary product
1.2.2. Uses advised against
Safety Data Sheet only for the professional user., For veteri- nary use only, Refer to the product insert for complete instruc- tions on usage
supplier name
Boehringer Ingelheim AH USA
Emergency telephone
+1 703-527-3887, +1 703-741-5970
Icons in SDS
Company Information
company name
Boehringer Ingelheim AH USA
e-mail address of the competent person responsible for the Safety Data Sheet
EHS-Services@Boehringer-Ingelheim.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H227, H302+H332, H315, H317, H319, H335, H360, H372
Hazard statements
Code
Statements
H227
Combustible liquid
Section 2
SECTION 2: Hazards identification
Other hazards
The pharmacological effect of the medicament has to be considered (see package leaflet) This drug is not subject to the labelling requirements under the Globally Harmonized System (GHS)
Signal word
Danger
Hazard statements
H227 Combustible liquid. H302 + H332 Harmful if swallowed or if inhaled. H315 Causes skin irritation. H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. H335 May cause respiratory irritation. H360 May damage fertility or the unborn child. H372 Causes damage to organs (Central nervous system) through prolonged or repeated exposure.
Prevention
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P210 Keep away from heat/ sparks/ open flames/ hot surfaces. No smoking. P260 Do not breathe mist or vapours. P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P271 Use only outdoors or in a well-ventilated area. P272 Contaminated work clothing must not be allowed out of the workplace. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection.
Response
P301 + P312 + P330 IF SWALLOWED: Call a POISON CENTER/ doctor if you feel unwell. Rinse mouth. P302 + P352 IF ON SKIN: Wash with plenty of soap and water. P304 + P340 + P312 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/ doctor if you feel unwell. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P333 + P313 If skin irritation or rash occurs: Get medical advice/ P337 + P313 If eye irritation persists: Get medical advice/ atten- tion. P362 Take off contaminated clothing and wash before reuse. P370 + P378 In case of fire: Use dry sand, dry chemical or al- cohol-resistant foam to extinguish.
Storage
P403 + P233 Store in a well-ventilated place. Keep container tightly closed. P403 + P235 Store in a well-ventilated place. Keep cool. P405 Store locked up.
Disposal
P501 Dispose of contents/ container to an approved waste dis- posal plant.
2.1 Classification of the substance or mixture
1910.1200) Hazards for the product as supplied Flammable liquids : Category 4 Acute toxicity (Oral) : Category 4 Acute toxicity (Inhalation) : Category 4 Skin irritation : Category 2 Eye irritation : Category 2A Skin sensitisation : Category 1 Reproductive toxicity : Category 1B Specific target organ toxicity : Category 3 (Respiratory system) - single exposure Specific target organ toxicity : Category 1 (Central nervous system) - repeated exposure Other hazards The pharmacological effect of the medicament has to be considered (see package leaflet). This drug is not subject to the labelling requirements under the Globally Harmonized System (GHS)
